These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7891820)

  • 21. PKCε deficits in Alzheimer's disease brains and skin fibroblasts.
    Khan TK; Sen A; Hongpaisan J; Lim CS; Nelson TJ; Alkon DL
    J Alzheimers Dis; 2015; 43(2):491-509. PubMed ID: 25125477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment.
    Gattaz WF; Forlenza OV; Talib LL; Barbosa NR; Bottino CM
    J Neural Transm (Vienna); 2004 May; 111(5):591-601. PubMed ID: 15088152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of human platelet protein kinase C-beta 2 in vivo in response to acute hyperglycemia.
    Pirags V; Assert R; Haupt K; Schatz H; Pfeiffer A
    Exp Clin Endocrinol Diabetes; 1996; 104(6):431-40. PubMed ID: 9021343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets.
    Wang F; Naik UP; Ehrlich YH; Osada S; Ohno S; Kornecki E
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):401-6. PubMed ID: 7487874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type.
    Oreland L; Gottfries CG
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):533-40. PubMed ID: 3797686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PKC isoenzymes in equine platelets and stimulus induced activation.
    Aktan I; Dunkel B; Cunningham FM
    Vet Immunol Immunopathol; 2011 Jun; 141(3-4):276-82. PubMed ID: 21513989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise reduces age-dependent decrease in platelet protein kinase C activity and translocation.
    Wang HY; Bashore TR; Friedman E
    J Gerontol A Biol Sci Med Sci; 1995 Jan; 50A(1):M12-6. PubMed ID: 7814783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Zhao S; Zhao J; Zhang T; Guo C
    Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome c oxidase is decreased in Alzheimer's disease platelets.
    Cardoso SM; Proença MT; Santos S; Santana I; Oliveira CR
    Neurobiol Aging; 2004 Jan; 25(1):105-10. PubMed ID: 14675736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease.
    Parker WD; Mahr NJ; Filley CM; Parks JK; Hughes D; Young DA; Cullum CM
    Neurology; 1994 Jun; 44(6):1086-90. PubMed ID: 8208406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are thrombocyte membranes altered in Alzheimer's disease? A morphometric and biochemical study.
    Bosman GJ; Schuurmans Stekhoven JH; Melenhorst JJ; Van Zuylen AJ; Bartholomeus IG; Van Kalmthout PJ; De Grip WJ
    Neurobiol Aging; 1992; 13(6):711-6. PubMed ID: 1491736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral microvessels in Alzheimer's have reduced protein kinase C activity.
    Grammas P; Moore P; Botchlet T; Hanson-Painton O; Cooper DR; Ball MJ; Roher A
    Neurobiol Aging; 1995; 16(4):563-9. PubMed ID: 8544906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced phosphatidylinositol kinase activity in Alzheimer's disease: effects of age and onset.
    Jolles J; Bothmer J; Markerink M; Ravid R
    Dementia; 1993; 4(2):81-6. PubMed ID: 8395284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet beta-secretase activity is increased in Alzheimer's disease.
    Johnston JA; Liu WW; Coulson DT; Todd S; Murphy S; Brennan S; Foy CJ; Craig D; Irvine GB; Passmore AP
    Neurobiol Aging; 2008 May; 29(5):661-8. PubMed ID: 17174011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions.
    Schneider LS; Severson JA; Chui HC; Pollock VE; Sloane RB; Fredrickson ER
    Psychiatry Res; 1988 Sep; 25(3):311-22. PubMed ID: 2847206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral serotonin in Alzheimer's disease.
    Kumar AM; Sevush S; Kumar M; Ruiz J; Eisdorfer C
    Neuropsychobiology; 1995; 32(1):9-12. PubMed ID: 7566524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of protein kinase C subspecies in human platelets.
    Tsukuda M; Asaoka Y; Sekiguchi K; Kikkawa U; Nishizuka Y
    Biochem Biophys Res Commun; 1988 Sep; 155(3):1387-95. PubMed ID: 3140809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The differences in Ca(2+)-sensitivity of protein kinase C in platelets from Wistar Kyoto rat and stroke-prone spontaneously hypertensive rat.
    Ikeda M; Onda T; Tomita I; Tomita T
    Thromb Res; 1996 Jun; 82(5):417-27. PubMed ID: 8771702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine dephosphorylation, but not phosphorylation, of p130Cas is dependent on integrin alpha IIb beta 3-mediated aggregation in platelets: implication of p130Cas involvement in pathways unrelated to cytoskeletal reorganization.
    Ohmori T; Yatomi Y; Inoue K; Satoh K; Ozaki Y
    Biochemistry; 2000 May; 39(19):5797-807. PubMed ID: 10801330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.
    Stephenson DT; Lemere CA; Selkoe DJ; Clemens JA
    Neurobiol Dis; 1996 Feb; 3(1):51-63. PubMed ID: 9173912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.